Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact
Submitted by
admin
on February 19, 2018 - 11:46am
Source:
Endpoints
News Tags:
Eli Lilly
rheumatoid arthritis
Hanmi Pharmaceutical
clinical trials
Headline:
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact
Do Not Allow Advertisers to Use My Personal information
